Table 25-2.
Diseases and Risk Factors | Both Sexes | Total Females | White Females | Black Females | Mexican American Females |
---|---|---|---|---|---|
Smoking | |||||
Prevalence, 2012* | 42.1 M (18.1%) | 19.1 M (15.9%) | 19.2% | 14.2% | 7.5%† |
PA‡ | |||||
Prevalence, 2012* | 20.7% | 17.1% | 19.9% | 10.8% | 12.2%† |
Overweight and obesity | |||||
Prevalence, 2010 | |||||
Overweight and obesity, BMI >25.0 kg/m2§ | 154.7 M (68.2%) | 74.8 M (63.7%) | 60.2% | 79.9% | 78.2% |
Obesity, BMI >30.0 kg/m2§ | 78.4 M (34.6%) | 41.6 M (35.6%) | 32.5% | 53.9% | 44.8% |
Blood cholesterol | |||||
Prevalence, 2010 | |||||
Total cholesterol >200 mg/dL§ | 98.9 M (43.4%) | 53.6 M (44.9%) | 45.8% | 40.7% | 44.7% |
Total cholesterol >240 mg/dL§ | 31.9 M (13.8%) | 17.9 M (14.7%) | 15.6% | 11.7% | 13.5% |
LDL cholesterol >130 mg/dL§ | 71.0 M (31.1%) | 35.8 M (30.0%) | 29.3% | 31.2% | 30.4% |
HDL cholesterol <40 mg/dL§ | 48.7 M (21.8%) | 14.1 M (12.3%) | 12.4% | 10.2% | 15.1% |
HBP | |||||
Prevalence, 2010§ | 77.9 M (33.0%) | 40.7 M (32.2%) | 30.7% | 47.0% | 28.8% |
Mortality, 2010|| | 63 119 | 34 746 | 26 798 | 6923 | N/A |
DM | |||||
Prevalence, 2010 | |||||
Physician-diagnosed DM§ | 19.7 M (8.3%) | 10.1 M (7.9%) | 6.2% | 15.4% | 12.0% |
Undiagnosed DM§ | 8.2 M (3.5%) | 2.9 M (2.3%) | 1.8% | 2.9% | 4.7% |
Prediabetes§ | 87.3 M (38.2%) | 33.6 M (30.5%) | 30.0% | 29.0% | 31.9% |
Incidence, diagnosed DM§ | 1.9 M | N/A | N/A | N/A | N/A |
Mortality, 2010|| | 69 071 | 33 581 | 25 764 | 6486 | N/A |
Total CVD | |||||
Prevalence, 2010§ | 83.6 M (35.3%) | 42.9 M (34.0%) | 32.4% | 48.9% | 30.7% |
Mortality, 2010||¶ | 787 650 | 400 332 | 342 581 | 49 977 | N/A |
Stroke | |||||
Prevalence, 2010§ | 6.8 M (2.8%) | 3.8 M (3.0%) | 2.9% | 4.7% | 1.4% |
New and recurrent strokes|| | 795.0 K | 425.0 K | 365.0 K | 60.0 K | N/A |
Mortality, 2010|| | 129 476 | 77 109 | 65 695 | 9027 | N/A |
CHD | |||||
Prevalence, CHD, 2010§ | 15.4 M (6.4%) | 6.6 M (5.1%) | 4.6% | 7.1% | 5.3% |
Prevalence, MI, 2010§ | 7.6 M (2.9%) | 2.6 M (1.7%) | 1.5% | 2.3% | 1.7% |
Prevalence, AP, 2010§ | 7.8 M (3.2%) | 4.1 M (3.2%) | 2.8% | 5.4% | 3.3% |
New and recurrent CHD#** | 915.0 K | 385.0 K | 330.0 K | 55.0 K | N/A |
New and recurrent MI** | 720.0 K | 300.0 K | N/A | N/A | N/A |
Incidence, AP (stable angina)‡‡ | 565.0 K | 195.0 K | N/A | N/A | N/A |
Mortality, 2010, CHD|| | 379 559 | 171 979 | 148 891 | 19 015 | N/A |
Mortality, 2010, MI|| | 122 071 | 54 636 | 47 023 | 6298 | N/A |
HF | |||||
Prevalence, 2010§ | 5.1 M (2.1%) | 2.4 M (1.8%) | 1.8% | 3.0% | 1.1% |
Incidence, 2010‡‡ | 825 000 | 430 000 | 375 000 | 55 000 | N/A |
Mortality, 2010|| | 57 757 | 33 372 | 29 750 | 3084 | N/A |
AP indicates angina pectoris (chest pain); BMI, body mass index; CHD, coronary heart disease (includes heart attack, angina pectoris chest pain, or both); CVD, cardiovascular disease; DM, diabetes mellitus; HBP, high blood pressure; HDL, high-density lipoprotein; HF, heart failure; K, thousands; LDL, low-density lipoprotein; M, millions; MI, myocardial infarction (heart attack); N/A, data not available; and PA, physical activity.
Age ≥18 y (National Health Interview Survey).
All Hispanic (National Health Interview Survey).
Met 2008 full Federal PA guidelines for adults.
Age ≥20 y.
All ages.
Total CVD mortality includes deaths from congenital heart disease.
New and recurrent MI and fatal CHD.
Age ≥35 y.
Age ≥45 y.